Yabao Pharmaceutical Group Co Ltd Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd asset resilience ratio. Yabao Pharmaceutical Group Co Ltd (600351) has an Asset Resilience Ratio of 0.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600351 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Yabao Pharmaceutical Group Co Ltd (2003–2020)
Asset resilience ratio of Yabao Pharmaceutical Group Co Ltd from 2003 to 2020. This chart shows how Yabao Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read Yabao Pharmaceutical Group Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Yabao Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 600351 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.96 Million | 0.27% |
| Total Liquid Assets | CN¥8.96 Million | 0.27% |
Asset Resilience Insights
- Limited Liquidity: Yabao Pharmaceutical Group Co Ltd maintains only 0.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Yabao Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Yabao Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Yabao Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (2003–2020)
Yabao Pharmaceutical Group Co Ltd asset resilience ratio by year from 2003 to 2020. The table below shows the annual Asset Resilience Ratio data for Yabao Pharmaceutical Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.00% | CN¥100.00K ≈ $14.63K |
CN¥4.01 Billion ≈ $587.42 Million |
-0.34pp |
| 2018-12-31 | 0.35% | CN¥16.69 Million ≈ $2.44 Million |
CN¥4.83 Billion ≈ $706.23 Million |
+0.21pp |
| 2016-12-31 | 0.14% | CN¥5.76 Million ≈ $843.34K |
CN¥4.21 Billion ≈ $615.40 Million |
+0.11pp |
| 2014-12-31 | 0.02% | CN¥785.00K ≈ $114.87K |
CN¥3.18 Billion ≈ $466.07 Million |
-0.37pp |
| 2013-12-31 | 0.40% | CN¥12.69 Million ≈ $1.86 Million |
CN¥3.20 Billion ≈ $468.60 Million |
+0.34pp |
| 2012-12-31 | 0.06% | CN¥1.70 Million ≈ $248.05K |
CN¥2.88 Billion ≈ $422.08 Million |
+0.01pp |
| 2008-12-31 | 0.04% | CN¥735.70K ≈ $107.66K |
CN¥1.67 Billion ≈ $245.00 Million |
-0.14pp |
| 2005-12-31 | 0.18% | CN¥2.04 Million ≈ $298.95K |
CN¥1.13 Billion ≈ $166.06 Million |
-0.04pp |
| 2004-12-31 | 0.22% | CN¥2.09 Million ≈ $305.97K |
CN¥937.81 Million ≈ $137.23 Million |
+0.19pp |
| 2003-12-31 | 0.03% | CN¥200.01K ≈ $29.27K |
CN¥664.93 Million ≈ $97.30 Million |
-- |
About Yabao Pharmaceutical Group Co Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 a… Read more